Christian Felder's bio:

Dr. Christian Felder received his PhD in 1987 in the Dept. of Biochemistry at Georgetown University School of Medicine. He joined the NIMH in Bethesda, MD as a staff fellow in 1987 and completed his postdoctoral training in the laboratory of Dr. Julius Axelrod in 1990. He remained at the NIMH as Head of the Unit on Cell and Molecular Signaling where his lab focused on the molecular mechanisms of neurotransmitter action and their role in neuropsychiatric diseases. In 1997, he joined the Neuroscience Division at Eli Lilly & Co. in Indianapolis, IN and has held both research and management positions in the US and UK. Dr. Felder holds several editorial positions on leading journals, has published over 120 peer reviewed manuscripts and book chapters, sits on NIH study section reviews, and is a recognized expert in Neuropharmacology receiving both national and international invitations to speak at key conferences. He is currently a Research Fellow in Neuroscience leading research and drug development projects focused on novel approaches for the treatment of psychiatric and neurological disorders.

DISCLOSURE: Dr. Felder is an employee of Eli Lilly & Co. and receives salary.

Christian Felder's posts:

Mental Health Drug Discovery: From Probabilistic to Patient Focused Approaches

Mental health issues and substance abuse continues to be an underserved yet high unmet medical need.  Based on past and [MORE]